Role of glycogen synthase kinase-3β in dependence and abuse liability of alcohol
- 23 December 2023
- journal article
- review article
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 59 (2)
Abstract
Alcohol is a major abused drug worldwide that contributes substantially to health and social problems. These problems result from acute alcohol overuse as well as chronic use, leading to alcohol use disorder (AUD). A major goal of this field is to establish a treatment for alcohol abuse and dependence in patients with AUD. The central molecular mechanisms of acute alcohol actions have been extensively investigated in rodent models. One of the central mechanisms that may be involved is glycogen synthase kinase-3β (GSK-3β) activity, a key enzyme involved in glycogen metabolism but which has crucial roles in numerous cellular processes. Although the exact mechanisms leading from acute alcohol actions to these chronic changes in GSK-3β function are not yet clear, GSK-3β nonetheless constitutes a potential therapeutic target for AUD by reducing its function using GSK-3β inhibitors. This review is focused on the correlation between GSK-3β activity and the degree of alcohol consumption. Research articles regarding investigation of effect of GSK-3β on alcohol consumption in rodents were searched on PubMed, Embase, and Scopus databases using keywords “glycogen synthase kinase,” “alcohol (or ethanol),” “intake (or consumption),” and evaluated by changes in ratios of pGSK-3βSer9/pGSK-3β. In animal experiments, GSK-3β activity decreases in the brain under forced and voluntary alcohol consumption while GSK-3β activity increases under alcohol-seeking behavior. Several pieces of evidence suggest that alterations in GSK-3β function are important mediators of chronic ethanol actions, including those related to alcohol dependence and the adverse effects of chronic ethanol exposure.Keywords
Funding Information
- Japan Society for the Promotion of Science (21 K06591)
This publication has 87 references indexed in Scilit:
- Neurological characterization of mice deficient in GSK3α highlight pleiotropic physiological functions in cognition and pathological activity as Tau kinaseMolecular Brain, 2013
- β-Arrestin2 mediates the initiation and progression of myeloid leukemiaProceedings of the National Academy of Sciences, 2012
- Essential requirement for β-arrestin2 in mouse intestinal tumors with elevated Wnt signalingProceedings of the National Academy of Sciences, 2012
- AKT Signaling Pathway in the Nucleus Accumbens Mediates Excessive Alcohol Drinking BehaviorsBiological Psychiatry, 2011
- Beyond cAMP: the regulation of Akt and GSK3 by dopamine receptorsFrontiers in Molecular Neuroscience, 2011
- GSK-3β activity and hyperdopamine-dependent behaviorsNeuroscience & Biobehavioral Reviews, 2011
- Aldehyde dehydrogenase 2 knockout accentuates ethanol-induced cardiac depression: Role of protein phosphatasesJournal of Molecular and Cellular Cardiology, 2010
- Tryptophan hydroxylase 2 genotype determines brain serotonin synthesis but not tissue content in C57Bl/6 and BALB/c congenic miceNeuroscience Letters, 2010
- Overexpression of glycogen synthase kinase 3β sensitizes neuronal cells to ethanol toxicityJournal of Neuroscience Research, 2009
- The GSK3 hypothesis of Alzheimer’s diseaseJournal of Neurochemistry, 2007